Age-Related Changes Affecting Benzodiazepine Metabolism
As the body ages, several physiological changes occur that significantly impact how medications, including benzodiazepines, are processed. This altered pharmacokinetics is a primary reason why are benzos avoided in older adults.
Older adults experience decreased metabolism, particularly of long-acting benzodiazepines, which can lead to drug accumulation and prolonged sedation. Increased body fat and the fat-solubility of benzos also extend their half-life, keeping them in the system longer. Furthermore, central nervous system receptors become more sensitive with age, meaning even low doses can cause significant sedation and other effects.
The Spectrum of Adverse Effects in Older Adults
The physiological changes lead to more common and severe adverse effects in older adults.
Cognitive Impairment
Benzodiazepines can impair memory, concentration, and cognitive function, potentially mimicking or worsening dementia. Memory problems can occur even at therapeutic doses. Discontinuation may improve cognition in some cases.
Increased Risk of Falls and Accidents
Sedation and poor coordination from benzos significantly increase the risk of falls and fractures in seniors. Studies show a substantial increase in hip fracture risk. The risk of accidents, including motor vehicle accidents, is also higher.
Physical Dependence and Withdrawal
Older adults can develop dependence even with short-term use at therapeutic doses. Abruptly stopping can cause withdrawal symptoms like anxiety, confusion, and seizures. A slow, supervised taper is necessary for discontinuation. Guidelines like the AGS Beers Criteria [https://www.americangeriatrics.org/ags-beers-criteria] assist in deprescribing for seniors.
Long-Acting vs. Short-Acting Benzodiazepines in Seniors
The duration of action influences the risks in older adults.
| Factor | Short-Acting Benzos (e.g., Lorazepam, Temazepam) | Long-Acting Benzos (e.g., Diazepam, Flurazepam) |
|---|---|---|
| Metabolism | Less affected by aging | Significantly slowed by aging |
| Accumulation Risk | Lower risk | Higher risk; effects can persist |
| Daytime Impairment | More pronounced immediately after dosing | Significant concern |
| Withdrawal Risk | Higher risk of severe rebound symptoms | Slower elimination may attenuate symptoms |
| Fall Risk | Increased risk shortly after dose | Increased risk from general sedation |
Safer Alternatives and Best Practices for Anxiety and Insomnia
Given the risks, safer alternatives are preferred. Non-pharmacological methods are often the first choice.
-
Non-Pharmacological Approaches
- Cognitive Behavioral Therapy for Insomnia (CBTI): The standard treatment for insomnia.
- Improved Sleep Hygiene: Establishing routine and optimizing the sleep environment.
- Regular Exercise: Effective for improving sleep and reducing anxiety.
- Mindfulness and Relaxation Techniques: Helpful for managing anxiety and improving sleep.
-
Pharmacological Alternatives
- Selective Serotonin Reuptake Inhibitors (SSRIs): Often first-line for anxiety with lower dependence risk.
- Buspirone: Non-addictive and generally well-tolerated.
- Low-Dose Antidepressants: Can be used for insomnia with a better side effect profile.
- Melatonin and Melatonin Enhancers: Help regulate sleep-wake cycles with minimal dependence risk.
Conclusion
Why are benzos avoided in older adults is primarily due to age-related physiological changes that heighten risks. Increased brain sensitivity and slower metabolism lead to a higher risk of falls, cognitive decline, and dependence. Safer alternatives, especially non-pharmacological therapies, are prioritized to maintain the health and safety of older adults.
